Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
VKTX
VKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VKTX News
Investment Opportunities in GLP-1 Drugs in Healthcare
1d ago
Fool
Viking Therapeutics: A Potential Obesity Market Leader
2d ago
Fool
Viking Therapeutics Targets Billion-Dollar Obesity Market
2d ago
NASDAQ.COM
Viking Therapeutics to Attend Investor Conferences
Apr 10 2026
PRnewswire
Viking Therapeutics to Attend Multiple Investor Conferences
Apr 10 2026
Newsfilter
The 'Diabesity' Market Is Poised for Rapid Growth: Key Catalysts for Lilly and Novo Stocks.
Apr 07 2026
Barron's
Healthcare Stocks Performance in Economic Recession
Apr 04 2026
NASDAQ.COM
Iran Conflict Raises Recession Risks Amid Inflation
Apr 04 2026
Fool
Viking Therapeutics Faces Challenges in Weight Loss Market
Apr 03 2026
NASDAQ.COM
Viking Therapeutics Faces Major Clinical Challenges Ahead
Apr 03 2026
Fool
Wegovy Pill Shows Superior Weight Loss Over Foundayo
Apr 02 2026
CNBC
Pharma Acquisition Surge Fuels Weight Loss Drug Market
Apr 02 2026
stocktwits
Investment Opportunities in the Healthcare Sector
Mar 31 2026
Fool
Investment Opportunities in Biotech and Healthcare Systems
Mar 31 2026
NASDAQ.COM
Viking and Structure Intensify Competition in Obesity Drug Development
Mar 30 2026
stocktwits
Viking Therapeutics: A Dark Horse in the GLP-1 Market
Mar 29 2026
Fool
Show More News
